Ziprasidone for schizophrenia and severe mental illness
作者： Anne-Marie Bagnall , Jos Kleijnen , Maria Leitner , Ruth Lewis
DOI: 10.1002/14651858.CD001945
关键词:
摘要: … All randomised controlled trials that compared ziprasidone to other treatments for schizophrenia and schizophrenia‐like psychoses were included by independent assessment. …
sci-hub.se 参考文章(65)
Simon Gilbody, Anne-Marie Bagnall, Lorna Duggan, Arja Tuunainen, Risperidone versus other atypical antipsychotic medication for schizophrenia Cochrane Database of Systematic Reviews. ,vol. 9, pp. 002306- ,(2016) , 10.1002/14651858.CD002306.PUB2
D. G Altman, J M. Bland, Detecting skewness from summary information. BMJ. ,vol. 313, pp. 1200- 1200 ,(1996) , 10.1136/BMJ.313.7066.1200
Daniel E. Casey, The relationship of pharmacology to side effects The Journal of Clinical Psychiatry. ,vol. 58, pp. 55- 62 ,(1997)
Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa, Rahul Gandhi, Quetiapine for schizophrenia Cochrane Database of Systematic Reviews. ,(2004) , 10.1002/14651858.CD000967.PUB2
Lorna Duggan, Mark Fenton, John Rathbone, Roland Dardennes, Ahmed El‐Dosoky, Saroja Indran, Olanzapine for schizophrenia. Cochrane Database of Systematic Reviews. ,(2005) , 10.1002/14651858.CD001359
S H Zorn, D W Schulz, P A Seymour, A W Schmidt, H R Howard, J A Lowe, V Guanowsky, T F Seeger, S McLean, L A Lebel, Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. Journal of Pharmacology and Experimental Therapeutics. ,vol. 275, pp. 101- 113 ,(1995)
K.D. Wilner, R.A. Hansen, A.C. Johnson, J.J. Miceli, G. Apseloff, N. Gerber, Single and multiple dose pharmacokinetics of ziprasidone in healthy males European Neuropsychopharmacology. ,vol. 6, pp. 38- ,(1996) , 10.1016/0924-977X(96)87474-8
Peter F. Buckley, New dimensions in the pharmacologic treatment of schizophrenia and related psychoses The Journal of Clinical Pharmacology. ,vol. 37, pp. 363- 378 ,(1997) , 10.1002/J.1552-4604.1997.TB04314.X
Damon Mitchell, Corinne Hagger, Alexandra L. Wise, S. Charles Schulz, Effects of oral ziprasidone and risperidone on cognitive functioning in patients with schizophrenia or schizoaffective disorder: Preliminary data Schizophrenia Research. ,vol. 24, pp. 116- ,(1997) , 10.1016/S0920-9964(97)82325-0
J.E. Bradbury, S.H. Zorn, K.D. Wilner, J.J. Miceli, D. Wong, C.J. Bench, R.S.J. Frackowiak, The preclinical profile of the new antipsychotic, ziprasidone European Psychiatry. ,vol. 11, pp. 404s- 405s ,(1996) , 10.1016/0924-9338(96)89321-7